[Ip-health] OECD pricing policy study

[Aidan Hollis]

The OECD published on Wednesday a significant study of pharmaceutical
pricing policies in OECD countries.

"OECD's Pharmaceutical Pricing Policies in a Global Market details national
differences in the consumption and cost of medicines and outlines how prices
are established, exploring the advantages and disadvantages of various
policies and practices."

The full document is available to subscribers only. But an executive
summary, and individual country studies, are available at

www.oecd.org/document/44/0,3343,en_2649_37407_41382764_1_1_1_1,00.html


Aidan Hollis

Associate Professor
Department of Economics, University of Calgary


2500 University Dr NW,Calgary Alberta T2N 1N4 Canada
tel: +1 403 220 5861 fax: +1 403 220 5861
email: ahollis@ucalgary.ca
http://econ.ucalgary.ca/profiles/aidan-michael-hollis

Incentives for Global Health
http://www.healthimpactfund.org